Table 2 Statistical comparison of lipid metabolic ion differences among Groups.

From: Multiomics reveals metformin’s dual role in gut microbiome remodeling and hepatic metabolic reprogramming for MAFLD intervention

Comparison

pos_all

pos_up

pos_down

neg_all

neg_up

neg_down

all_regulate

MI/CDD

90

17

73

68

4

64

158

Control/CDD

2935

1110

1825

1651

601

1050

4586

MI/Control

2963

1813

1150

1460

973

487

4423

  1. Comparison: Comparative groups A/B, with B as the control; ALL: Total number of high-quality features used for quantification; Up: Number of features upregulated in sample A; Down: Number of features downregulated in sample A; pos: positive; neg: negative.
Back to article page